NEW YORK (Reuters Health) – Strainers that block cholesterol-blocking rely on other recent breast cancer scans are based on recent studies.
Researchers have found that high-cholesterol-resistant statins do not interfere with malignant tumor, but prevent it from spreading to other organs. Tumors and laboratory mice have found that tumors do not allow the lungs and liver to move.
These results suggest that the use of statins with chemotherapy drugs can be used as an effective treatment against women as one of the main causes of death in the data provided by the Pittsburgh Medical Center research team.
As reported by Daily Mail, researchers have used more than 2 to 10 milligrams of Athervastatin, which has genetically modified breast cancer to produce roughly 20 to 80 milligrams of grains of grains. "Lipitor" brand.
The results showed that cholesterol-lowering drugs did not affect tumor cancer and did not affect breast cancer and prevented the spread of various forms of oncological organism.
"These effects are important for several reasons: First, atorasattarin doses are used to reduce the density of the lipids in patients," said Alan Wells, professor of the Pittsburgh Medical Center, Patent Professor. Secondly, the effect of eryservatin on breast cancer has been determined, and the main cancer cells were not exposed to statins.
According to British Journal of Cancer, statins can be used with chemotherapy to cure illness.
According to breastcancer.org site, breast cancer deaths by American women are higher than all other cancerous diseases except lung cancer.
Approximately 41,000 American women are expected to die of breast cancer in 2018, but since 1989 the mortality rate has dropped.
Experts recommend early detection of breast cancer as it increases the life expectancy by 99% over 5 years, but if the tumors are spread to other parts of the body, this figure will drop to only 27%, as IV stages of breast cancer aggressive and chemotherapy-resistant.